Chemours (NYSE:CC) Posts Earnings Results

Key Points

• Chemours reported a quarterly earnings per share (EPS) of $0.58, exceeding analyst estimates by $0.12, while revenue rose by 5.0% compared to the same period last year.
• The company's stock price increased by 3.2%, reaching $12.60, with average trading volume of over 4 million shares.
• Chemours announced a dividend of $0.0875 per share, with a high payout ratio of 175.00%.

Chemours (NYSE:CC - Get Free Report) released its quarterly earnings results on Tuesday. The specialty chemicals company reported $0.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.46 by $0.12, Zacks reports. The business had revenue of $1.62 billion for the quarter, compared to analyst estimates of $1.57 billion. Chemours had a negative net margin of 7.19% and a positive return on equity of 35.14%. The business's revenue for the quarter was up 5.0% on a year-over-year basis. During the same period in the previous year, the company earned $0.38 earnings per share. Chemours updated its Q3 2025 guidance to EPS and its FY 2025 guidance to EPS.

Chemours Stock Performance

NYSE:CC traded up $0.01 during mid-day trading on Friday, hitting $12.19. The company's stock had a trading volume of 4,329,307 shares, compared to its average volume of 3,980,270. The business's fifty day moving average is $12.22 and its two-hundred day moving average is $13.30. The stock has a market cap of $1.82 billion, a price-to-earnings ratio of -4.35 and a beta of 1.61. The company has a debt-to-equity ratio of 17.16, a current ratio of 1.68 and a quick ratio of 0.83. Chemours has a 1 year low of $9.13 and a 1 year high of $22.38.

Chemours Cuts Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 12th. Shareholders of record on Friday, August 15th will be issued a $0.0875 dividend. This represents a $0.35 annualized dividend and a yield of 2.9%. The ex-dividend date of this dividend is Friday, August 15th. Chemours's dividend payout ratio is presently -12.50%.

Insider Transactions at Chemours

In related news, CFO Shane Hostetter purchased 4,450 shares of the firm's stock in a transaction on Monday, May 19th. The stock was bought at an average cost of $11.28 per share, with a total value of $50,196.00. Following the completion of the acquisition, the chief financial officer owned 59,694 shares of the company's stock, valued at $673,348.32. The trade was a 8.06% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Damian Gumpel acquired 13,400 shares of the company's stock in a transaction dated Monday, June 2nd. The shares were purchased at an average cost of $9.22 per share, for a total transaction of $123,548.00. Following the purchase, the insider directly owned 123,879 shares in the company, valued at approximately $1,142,164.38. This trade represents a 12.13% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired a total of 25,672 shares of company stock valued at $251,573 in the last quarter. Company insiders own 0.47% of the company's stock.

Institutional Trading of Chemours

A number of hedge funds have recently added to or reduced their stakes in the company. Empowered Funds LLC acquired a new stake in Chemours in the first quarter valued at approximately $403,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of Chemours by 149.3% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 43,243 shares of the specialty chemicals company's stock valued at $593,000 after buying an additional 25,899 shares in the last quarter. AQR Capital Management LLC acquired a new stake in Chemours in the 1st quarter valued at $161,000. Royal Bank of Canada grew its stake in Chemours by 6.8% in the 1st quarter. Royal Bank of Canada now owns 585,702 shares of the specialty chemicals company's stock valued at $7,926,000 after acquiring an additional 37,382 shares during the period. Finally, Baird Financial Group Inc. purchased a new stake in Chemours in the 1st quarter worth $148,000. 76.26% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the company. UBS Group reduced their target price on Chemours from $18.00 to $17.00 and set a "buy" rating on the stock in a research report on Wednesday, May 7th. Wall Street Zen downgraded shares of Chemours from a "hold" rating to a "sell" rating in a report on Wednesday, May 21st. The Goldman Sachs Group decreased their price objective on shares of Chemours from $21.00 to $14.00 and set a "neutral" rating for the company in a research report on Wednesday, May 14th. Royal Bank Of Canada upped their price target on shares of Chemours from $14.00 to $15.00 and gave the company an "outperform" rating in a research note on Thursday, July 3rd. Finally, Truist Financial decreased their price target on shares of Chemours from $27.00 to $22.00 and set a "buy" rating for the company in a report on Monday, April 14th. One analyst has rated the stock with a sell rating, three have given a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $17.38.

Chemours Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.